Preferred Label : piperazines;

MeSH definition : Compounds that are derived from PIPERAZINE; Compounds that are derived from PIPERAZINE.;

DeCS synonym : Piperazine;

MeSH annotation : PIPERAZINE is also available;

Codes EINECS : 203-808-3;

Is substance : O;

Details


Main resources

You can consult :

Compounds that are derived from PIPERAZINE
Compounds that are derived from PIPERAZINE.

https://ansm.sante.fr/tableau-atu-rtu/sotorasib-120-mg-comprimes-pellicules
2023
false
false
false
France
French
administration, oral
guidelines for drug use
sotorasib
sotorasib
carcinoma, non-small-cell lung
carcinoma, non-small-cell lung
bronchial neoplasms
bronchial neoplasms
summary of product characteristics
package leaflet
adult
neoplasm metastasis
sotorasib
piperazines
pyridines
pyrimidines
piperazines
pyridines
pyrimidines

---
https://www.has-sante.fr/jcms/p_3264802/fr/lynparza-olaparib-ovaire
2021
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
olaparib
administration, oral
antineoplastic agents
antineoplastic combined chemotherapy protocols
Bevacizumab/Olaparib Regimen
ovarian neoplasms
fallopian tube neoplasms
carcinoma
Advanced Primary Peritoneal Carcinoma
advanced primary peritoneal cancer
adult
Homologous Recombination Deficiency
phthalazines
piperazines

---
https://www.has-sante.fr/jcms/p_3264984/fr/lynparza-olaparib-prostate
2021
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
administration, oral
metastatic castration resistant prostate cancer
neoplasm metastasis
prostatic neoplasms, Castration-Resistant
antineoplastic agents
olaparib
olaparib
prostatic neoplasms, Castration-Resistant
mutation
genes, BRCA1
genes, BRCA2
phthalazines
piperazines

---
https://ansm.sante.fr/tableau-atu-rtu/fostemsavir-600-mg-comprime-a-liberation-prolongee
2021
false
false
false
France
French
package leaflet
summary of product characteristics
guidelines for drug use
Fostemsavir
Fostemsavir
administration, oral
drug resistance, multiple, viral
hiv infections
HIV-1
drug therapy, combination
adult
anti-hiv agents
anti-hiv agents
fostemsavir
hiv fusion inhibitors
hiv fusion inhibitors
organophosphates
organophosphates
piperazines
piperazines
fostemsavir

---
https://www.has-sante.fr/jcms/p_3293335/fr/tivicay-dolutegravir-sodique
2021
false
false
false
France
hiv infections
adult
adolescent
child
treatment outcome
insurance, health, reimbursement
dolutegravir
teratogens
pregnancy
evaluation of the transparency committee
dolutegravir sodium
HIV integrase inhibitors
dolutegravir
heterocyclic compounds, 3-ring
oxazines
piperazines
pyridones

---
https://www.has-sante.fr/jcms/p_3241358/fr/lynparza-cancer-de-la-prostate-metastatique-resistant-a-la-castration
2021
false
false
false
France
treatment outcome
insurance, health, reimbursement
Poly(ADP-ribose) Polymerase Inhibitors
olaparib
administration, oral
prostatic neoplasms, Castration-Resistant
neoplasm metastasis
adult
BRCA1 Gene Mutation
BRCA2 Gene Mutation
evaluation of the transparency committee
olaparib
phthalazines
piperazines

---
https://www.has-sante.fr/jcms/p_3271861/fr/rukobia-fostemsavir
2021
false
false
false
France
administration, oral
Delayed-Action preparations
treatment outcome
insurance, health, reimbursement
fostemsavir
fostemsavir
adult
HIV-1
hiv infections
hiv fusion inhibitors
anti-hiv agents
drug resistance, multiple, viral
multiresistant HIV-1 infection
evaluation of the transparency committee
organophosphates
piperazines

---
https://www.ema.europa.eu/en/medicines/human/EPAR/rukobia
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
Fostemsavir Tromethamine
Fostemsavir Tromethamine
fostemsavir
organophosphates
organophosphates
piperazines
piperazines
anti-hiv agents
anti-hiv agents
hiv infections
hiv fusion inhibitors
hiv fusion inhibitors
HIV-1
adult
acquired immunodeficiency syndrome
drug therapy, combination
drug resistance, multiple, viral
administration, oral
Delayed-Action preparations
product surveillance, postmarketing
aged
drug interactions
pregnancy
breast feeding
prodrugs
Temsavir
drug evaluation, preclinical
fostemsavir
fostemsavir
multiresistant HIV-1 infection

---
https://ansm.sante.fr/disponibilites-des-produits-de-sante/medicaments/lynparza-50-mg-gelule
2020
false
false
false
France
French
drug information
product recalls and withdrawals
olaparib
olaparib
antineoplastic agents
Carcinoma, Ovarian Epithelial
Serous Tubal Intraepithelial Carcinoma
Primary Peritoneal Carcinoma
fallopian tube neoplasms
peritoneal neoplasms
phthalazines
piperazines

---
https://www.ansm.sante.fr/actualites/les-medicaments-eupressyl-et-mediatensyl-ont-change-de-noms-et-sont-devenus-eupressyl-lp-et-mediatensyl-lp
2020
false
false
false
France
French
drug information
-
-
urapidil
Delayed-Action preparations
administration, oral
piperazines

---
https://www.has-sante.fr/jcms/p_3168614/fr/tagrisso
2020
false
false
false
France
administration, oral
adult
insurance, health, reimbursement
antineoplastic agents
protein kinase inhibitors
neoplasm metastasis
carcinoma, non-small-cell lung
bronchial neoplasms
Activating EGFR Gene Mutation
osimertinib
osimertinib
evaluation of the transparency committee
piperazines
acrylamides
aniline compounds

---
https://www.ansm.sante.fr/actualites/lynparza-dans-les-cancers-gynecologiques-un-document-pour-guider-les-patientes-lors-du-passage-des-gelules-aux-comprimes
2020
false
false
false
France
French
patients guideline
guidelines for drug use
olaparib
Poly(ADP-ribose) Polymerase Inhibitors
administration, oral
genital neoplasms, female
olaparib
capsules
tablets
phthalazines
piperazines

---
https://ansm.sante.fr/uploads/2020/10/19/20201019-lettre-hcp-pui-atuc-lynparza.pdf
2019
false
false
false
France
French
pharmacovigilance note
medication errors
tablets
capsules
olaparib
patient education handout
phthalazines
piperazines

---
https://www.has-sante.fr/jcms/p_3135598/fr/lynparza
2019
false
false
false
France
olaparib
treatment outcome
insurance, health, reimbursement
administration, oral
Carcinoma, Ovarian Epithelial
antineoplastic agents
evaluation of the transparency committee
olaparib
phthalazines
piperazines

---
https://www.has-sante.fr/jcms/p_3135574/fr/lynparza
2019
false
false
false
France
French
evaluation of the transparency committee
insurance, health, reimbursement
treatment outcome
olaparib
olaparib
administration, oral
breast neoplasms
mutation
genes, BRCA1
genes, BRCA2
breast neoplasms
Poly(ADP-ribose) Polymerase Inhibitors
phthalazines
piperazines

---
https://www.has-sante.fr/jcms/c_2964747/fr/ibrance
2019
false
false
false
France
treatment outcome
palbociclib
antineoplastic agents
protein kinase inhibitors
palbociclib
antineoplastic combined chemotherapy protocols
Letrozole
postmenopause
breast neoplasms
Fulvestrant
Hormone receptor positive malignant neoplasm of breast (disorder)
administration, oral
evaluation of the transparency committee
piperazines
pyridines

---
https://www.has-sante.fr/jcms/p_3118407/fr/urapidil-stragen
2019
false
false
false
France
urapidil
insurance, health, reimbursement
treatment outcome
hypertension, malignant
antihypertensive agents
hypertensive encephalopathy
hypotension, controlled
Aortic Dissection
Perioperative hypertension (disorder)
drugs, generic
Hypertensive emergency
evaluation of the transparency committee
urapidil
piperazines

---
https://www.has-sante.fr/jcms/c_2964747/fr/ibrance-palbociclib-inhibiteur-de-proteine-kinase
2019
false
false
false
France
guidelines for drug use
protein kinase inhibitors
palbociclib
antineoplastic combined chemotherapy protocols
Letrozole
breast neoplasms
Hormone receptor positive malignant neoplasm of breast (disorder)
Human epidermal growth factor 2 negative carcinoma of breast (disorder)
administration, oral
postmenopause
evaluation of the transparency committee
palbociclib
piperazines
pyridines
piperazines
pyridines

---
https://pharmactuel.com/index.php/pharmactuel/article/view/1265
2019
false
false
false
false
France
comparative effectiveness research
treatment outcome
EGFR Gene Mutation
protein kinase inhibitors
protein-tyrosine kinases
antineoplastic agents
Gefitinib
Afatinib
clinical trials, phase iii as topic
antineoplastic agents
protein kinase inhibitors
lung neoplasms
lung neoplasms
carcinoma, non-small-cell lung
osimertinib
osimertinib
Tyrosine Kinase Inhibitors
critical appraisal or critical reading
carcinoma, non-small-cell lung
piperazines
piperazines
acrylamides
aniline compounds
acrylamides
aniline compounds

---
https://www.has-sante.fr/portail/jcms/c_2964747/fr/ibrance
2019
false
false
false
France
French
palbociclib
antineoplastic agents
protein kinase inhibitors
breast neoplasms
neoplasm metastasis
Locally Advanced Malignant Neoplasm
antineoplastic combined chemotherapy protocols
Hormone receptor positive malignant neoplasm of breast (disorder)
administration, oral
Cyclin-Dependent kinase 4
Cyclin-Dependent kinase 6
survival analysis
Progression-Free survival
Human epidermal growth factor 2 negative carcinoma of breast (disorder)
treatment outcome
evaluation of the transparency committee
postmenopause
Stage IV Breast Cancer AJCC v6 and v7
Locally advanced breast cancer
HER2/Neu Negative
palbociclib
piperazines
pyridines
disease-free survival
Progression-Free Survival

---
https://www.ansm.sante.fr/actualites/nouvelle-mesure-dacces-a-linnovation-atu-de-cohorte-dextension-dindication-pour-lutilisation-de-lynparza-100-mg-et-150-mg-comprimes-olaparib-dans-certains-cancers-gynecologiques
2019
false
false
false
France
French
ovarian neoplasms
fallopian tube neoplasms
peritoneal neoplasms
olaparib
olaparib
drug information
antineoplastic agents
advanced primary peritoneal cancer
carcinoma
Maintenance Therapy
phthalazines
piperazines

---
https://www.has-sante.fr/portail/jcms/c_2904637/fr/reagila
2019
false
false
false
France
French
treatment outcome
cariprazine
cariprazine
schizophrenia
antipsychotic agents
adult
administration, oral
evaluation of the transparency committee
piperazines

---
https://www.has-sante.fr/portail/jcms/c_2893483/fr/lynparza
2019
false
false
false
France
French
olaparib
olaparib
evaluation of the transparency committee
phthalazines
piperazines

---
http://www.pharmactuel.com/index.php/pharmactuel/article/view/1204
2018
false
false
false
Canada
French
osimertinib
due to
Pemetrexed
mutation
Chemotherapy
"u" lymphocyte
platinum
receptors, opioid, mu
platinum, nos
neoplasm, malignant
Cell
carcinoma, non-small-cell lung
small cell lung carcinoma
drug therapy
base, nos
chemotherapy, nos
treaties
Lung cancer
chemotherapy
small cell lung carcinoma
international cooperation
piperazines
ErbB Receptors
acrylamides
aniline compounds
acrylamides
aniline compounds

---
https://www.has-sante.fr/portail/jcms/c_2794988/fr/tagrisso-osimertinib-inhibiteur-de-tyrosine-kinase
https://www.has-sante.fr/portail/jcms/c_2794988/fr/tagrisso
2017
false
false
false
false
France
French
treatment outcome
piperazines
adult
carcinoma, non-small-cell lung
Advanced Malignant Neoplasm
neoplasm metastasis
mutation
antineoplastic agents
carcinoma, non-small-cell lung
administration, oral
protein kinase inhibitors
Tyrosine Kinase Inhibitor
protein-tyrosine kinases
evaluation of the transparency committee
insurance, health, reimbursement
survival analysis
osimertinib
guidelines for drug use
EGFR NP_005219.2:p.T790M
comparative effectiveness research
osimertinib
Tyrosine Kinase Inhibitors
ErbB Receptors
acrylamides
aniline compounds

---
https://www.ema.europa.eu/medicines/human/EPAR/Reagila
2017
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
cariprazine
cariprazine
cariprazine
drug monitoring
product surveillance, postmarketing
schizophrenia
antipsychotic agents
antipsychotic agents
adult
administration, oral
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
piperazines
piperazines

---
https://www.has-sante.fr/portail/jcms/c_2761877/fr/ibrance
2017
false
false
false
France
French
palbociclib
antineoplastic agents
protein kinase inhibitors
breast neoplasms
neoplasm metastasis
Locally Advanced Malignant Neoplasm
antineoplastic combined chemotherapy protocols
Hormone receptor positive malignant neoplasm of breast (disorder)
administration, oral
Cyclin-Dependent kinase 4
Cyclin-Dependent kinase 6
survival analysis
Progression-Free survival
Human epidermal growth factor 2 negative carcinoma of breast (disorder)
treatment outcome
evaluation of the transparency committee
postmenopause
Stage IV Breast Cancer AJCC v6 and v7
Locally advanced breast cancer
HER2/Neu Negative
palbociclib
piperazines
pyridines
disease-free survival

---
http://www.has-sante.fr/portail/jcms/c_2676714/fr/tagrisso
http://www.has-sante.fr/portail/jcms/c_2676714/fr/tagrisso-osimertinib-inhibiteur-de-tyrosine-kinase
2016
false
false
false
France
French
treatment outcome
piperazines
adult
carcinoma, non-small-cell lung
Advanced Malignant Neoplasm
neoplasm metastasis
mutation
antineoplastic agents
carcinoma, non-small-cell lung
administration, oral
protein kinase inhibitors
Tyrosine Kinase Inhibitor
protein-tyrosine kinases
evaluation of the transparency committee
insurance, health, reimbursement
survival analysis
osimertinib
guidelines for drug use
EGFR NP_005219.2:p.T790M
osimertinib
Tyrosine Kinase Inhibitors
ErbB Receptors
acrylamides
aniline compounds

---
http://www.prescrire.org/Fr/3/31/52057/0/NewsDetails.aspx
2016
false
false
false
France
French
french abstract
survival
olaparib
ovary
life support care
quality of life
olaparib
night time
qualitative
long
advanced
phthalazines
piperazines

---
https://www.ema.europa.eu/medicines/human/EPAR/Tagrisso
2016
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
piperazines
piperazines
pregnancy
breast feeding
drug interactions
adult
carcinoma, non-small-cell lung
Advanced Malignant Neoplasm
neoplasm metastasis
mutation
antineoplastic agents
antineoplastic agents
carcinoma, non-small-cell lung
genetic testing
administration, oral
protein kinase inhibitors
protein kinase inhibitors
Tyrosine Kinase Inhibitor
Tyrosine Kinase Inhibitor
protein-tyrosine kinases
product surveillance, postmarketing
drug monitoring
contraception
drug evaluation, preclinical
osimertinib
osimertinib
osimertinib
Tyrosine Kinase Inhibitors
ErbB Receptors
acrylamides
aniline compounds
acrylamides
aniline compounds

---
https://www.ema.europa.eu/medicines/human/EPAR/Ibrance
2016
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
palbociclib
palbociclib
drug approval
europe
antineoplastic agents
antineoplastic agents
protein kinase inhibitors
protein kinase inhibitors
breast neoplasms
neoplasm metastasis
Locally Advanced Malignant Neoplasm
antineoplastic combined chemotherapy protocols
Hormone receptor positive malignant neoplasm of breast (disorder)
administration, oral
Cyclin-Dependent kinase 4
Cyclin-Dependent kinase 6
survival analysis
Progression-Free survival
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
Human epidermal growth factor 2 negative carcinoma of breast (disorder)
palbociclib
piperazines
pyridines
disease-free survival
piperazines
pyridines

---
http://www.has-sante.fr/portail/jcms/c_2025252/fr/brintellix
http://www.has-sante.fr/portail/jcms/c_2025252/fr/brintellix-vortioxetine-antidepresseur
2015
false
false
false
France
French
evaluation of the transparency committee
administration, oral
guidelines for drug use
insurance, health, reimbursement
treatment outcome
vortioxetine hydrobromide
vortioxetine hydrobromide
vortioxetine
depressive disorder, major
adult
antidepressive agents
antidepressive agents
piperazines
sulfides
piperazines
sulfides
Vortioxetine
Vortioxetine

---
http://www.has-sante.fr/portail/jcms/c_2015058/fr/quelle-place-pour-les-benzodiazepines-dans-linsomnie-fiche-bum
2015
false
true
false
France
French
guidelines for drug use
sleep initiation and maintenance disorders
benzodiazepines
hypnotics and sedatives
benzodiazepines
hypnotics and sedatives
adult
aged
Duration of treatment (qualifier value)
time factors
lormetazepam
benzodiazepine derivatives
estazolam
nitrazepam
triazulenone
zopiclone
temazepam
withdrawing treatment
Therapy cessation
lorazepam
lorazepam
pyridines
piperazines
azabicyclo compounds
Zolpidem

---
https://www.ema.europa.eu/medicines/human/EPAR/Lynparza
2015
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
olaparib
olaparib
drug approval
europe
antineoplastic agents
antineoplastic agents
enzyme inhibitors
enzyme inhibitors
orphan drug production
adult
ovarian neoplasms
maintenance chemotherapy
Advanced Malignant Neoplasm
ovarian neoplasms
mutation
genes, BRCA1
genes, BRCA2
Recurrent Ovarian Carcinoma
neoplasm recurrence, local
fallopian tube neoplasms
Malignant Peritoneal Neoplasm
administration, oral
peritoneal neoplasms
Poly(ADP-ribose) polymerases
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
contraception
PARP1 protein, human
PARP2 protein, human
PARP3 protein, human
drug evaluation, preclinical
olaparib
cell cycle proteins
phthalazines
piperazines
phthalazines
piperazines

---
http://www.has-sante.fr/portail/jcms/c_2038097/fr/lynparza
http://www.has-sante.fr/portail/jcms/c_2038097/fr/lynparza-olaparib-inhibiteur-de-l-enzyme-parp
2015
false
false
false
France
French
evaluation of the transparency committee
administration, oral
olaparib
olaparib
treatment outcome
insurance, health, reimbursement
olaparib
adult
ovarian neoplasms
neoplasm recurrence, local
fallopian tube neoplasms
peritoneal neoplasms
enzyme inhibitors
enzyme inhibitors
antineoplastic agents
antineoplastic agents
Poly(ADP-ribose) polymerases
BRCA2 Gene Mutation
BRCA1 Gene Mutation
genes, BRCA1
genes, BRCA2
disease-free survival
Progression-Free survival
mutation
guidelines for drug use
phthalazines
piperazines
phthalazines
piperazines

---
IMOVANE (zopiclone) - New Dosage Recommendations to Minimize the Risk of Next-Day Impairment - For Health Professionals
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2014/42253a-fra.php
2014
false
false
false
Canada
French
English
pharmacovigilance note
zopiclone
zopiclone
guidelines for drug use
administration, oral
hypnotics and sedatives
sleep initiation and maintenance disorders
adult
aged
piperazines
azabicyclo compounds

---
https://reptox.cnesst.gouv.qc.ca/pages/fiche-complete.aspx?no_produit=141556&nom=N-Aminoéthyl+pipérazine
Canada
toxicological data sheet
piperazine
piperazines
Piperazine

---
http://www.cochrane.org/fr/CD001945
http://www.cochrane.org/fr/CD006627
2013
France
United Kingdom
French
review of literature
meta-analysis
schizophrenia
mental disorders
antipsychotic agents
piperazines
thiazoles
treatment outcome

---
http://www.cochrane.org/fr/CD007360
2012
United Kingdom
France
French
meta-analysis
prostatic hyperplasia
treatment outcome
adrenergic alpha-antagonists
naftopidil
lower urinary tract symptoms
naphthalenes
piperazines
prostatic hyperplasia
french abstract

---
http://www.cochrane.org/fr/CD002179
2010
United Kingdom
France
French
meta-analysis
treatment outcome
asthma
adult
child
piperazines
anti-asthmatic agents
oxatomide
french abstract
Childhood asthma (disorder)

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62457244
2010
France
French
-
piperazines
serotonin receptor agonists
adrenergic alpha-antagonists
antihypertensive agents
vasodilator agents
drug information

---
http://www.lecrat.eu/?s=Buclizine+-+APHILAN%C2%AE
2009
France
French
pregnancy
histamine h1 antagonists
histamine h1 antagonists
piperazines
infant, newborn
buclizine
buclizine
piperazines
drug information

---
http://medecine-pharmacie.univ-rouen.fr/jsp/saisie/liste_fichiergw.jsp?OBJET=DOCUMENT&CODE=1190377229762&LANGUE=0
2009
false
false
France
French
piperazines
medical oncology
pyrimidines
leukemia, myelogenous, chronic, bcr-abl positive
myeloproliferative disorders
educational course

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61119097
2009
France
French
cetirizine
piperazines
histamine H1 antagonists, non-sedating
levocetirizine
summary of product characteristics
package leaflet

---
http://www.has-sante.fr/portail/jcms/c_854637/glivec-ct-6889
http://www.has-sante.fr/portail/jcms/c_854122/glivec
2009
false
France
French
piperazines
pyrimidines
antibiotics, antineoplastic
imatinib
drug evaluation

---
http://www.lecrat.eu/?s=Zopiclone
2008
France
French
piperazines
pregnancy
hypnotics and sedatives
azabicyclo compounds
zopiclone
zopiclone
piperazines
azabicyclo compounds
popular works
drug information

---
http://www.meddispar.fr/medicaments/3284989
2008
France
French
piperazines
azabicyclo compounds
tablets
administration, oral
drugs, generic
drug prescriptions
legislation, drug
zopiclone
zopiclone
hypnotics and sedatives
drug information

---
http://www.meddispar.fr/medicaments/3474856
2008
France
French
azabicyclo compounds
tablets
administration, oral
piperazines
drugs, generic
drug prescriptions
legislation, drug
zopiclone
zopiclone
hypnotics and sedatives
drug information

---
http://www.meddispar.fr/medicaments/3605241
2008
France
French
zopiclone
zopiclone
hypnotics and sedatives
azabicyclo compounds
piperazines
administration, oral
tablets
drugs, generic
drug prescriptions
legislation, drug
drug information

---
http://www.lecrat.eu/?s=Oxatomide
2008
France
French
pregnancy
piperazines
anti-allergic agents
oxatomide
oxatomide
piperazines
drug information

---
http://www.meddispar.fr/medicaments/3529853
2007
France
French
piperazines
hypnotics and sedatives
drug prescriptions
legislation, drug
azabicyclo compounds
zopiclone
zopiclone
drug information

---
http://www.meddispar.fr/medicaments/3587810
2007
France
French
piperazines
hypnotics and sedatives
drug prescriptions
legislation, drug
azabicyclo compounds
zopiclone
zopiclone
drug information

---
http://www.meddispar.fr/medicaments/3587773
2007
France
French
piperazines
drug prescriptions
hypnotics and sedatives
legislation, drug
azabicyclo compounds
zopiclone
zopiclone
drug information

---
http://www.meddispar.fr/medicaments/3488746
2007
France
French
piperazines
hypnotics and sedatives
legislation, drug
drug prescriptions
azabicyclo compounds
zopiclone
zopiclone
drug information

---
http://www.meddispar.fr/medicaments/3488700
2007
France
French
piperazines
hypnotics and sedatives
drug prescriptions
legislation, drug
azabicyclo compounds
zopiclone
zopiclone
drug information

---
http://www.meddispar.fr/medicaments/3524749
2007
France
French
piperazines
hypnotics and sedatives
drug prescriptions
legislation, drug
azabicyclo compounds
zopiclone
zopiclone
drug information

---
http://www.meddispar.fr/medicaments/3528635
2007
France
French
piperazines
hypnotics and sedatives
drug prescriptions
legislation, drug
azabicyclo compounds
zopiclone
zopiclone
drug information

---
http://www.meddispar.fr/medicaments/3528629
2007
France
French
drug prescriptions
azabicyclo compounds
zopiclone
piperazines
hypnotics and sedatives
legislation, drug
zopiclone
drug information

---
http://www.meddispar.fr/medicaments/3548247
2007
France
French
zopiclone
piperazines
hypnotics and sedatives
legislation, drug
drug prescriptions
azabicyclo compounds
zopiclone
drug information

---
http://www.meddispar.fr/medicaments/3658384
2007
France
French
piperazines
hypnotics and sedatives
legislation, drug
drug prescriptions
azabicyclo compounds
zopiclone
zopiclone
drug information

---
http://www.meddispar.fr/medicaments/3614501
2007
France
French
piperazines
hypnotics and sedatives
legislation, drug
drug prescriptions
azabicyclo compounds
zopiclone
zopiclone
drug information

---
http://www.meddispar.fr/medicaments/3614518
2007
France
French
hypnotics and sedatives
legislation, drug
drug prescriptions
azabicyclo compounds
piperazines
zopiclone
zopiclone
drug information

---
http://www.meddispar.fr/medicaments/3677252
2007
France
French
piperazines
hypnotics and sedatives
drug prescriptions
legislation, drug
azabicyclo compounds
zopiclone
zopiclone
drug information

---
http://www.meddispar.fr/medicaments/3558926
2007
France
French
piperazines
hypnotics and sedatives
legislation, drug
drug prescriptions
azabicyclo compounds
zopiclone
zopiclone
drug information

---
http://www.meddispar.fr/medicaments/3677269
2007
France
French
piperazines
hypnotics and sedatives
drug prescriptions
legislation, drug
azabicyclo compounds
zopiclone
zopiclone
drug information

---
http://www.lecrat.eu/?s=L%C3%A9voc%C3%A9tirizine
2007
France
French
pregnancy
piperazines
cetirizine
histamine H1 antagonists, non-sedating
levocetirizine
breast feeding
levocetirizine
cetirizine
drug information

---
https://www.jle.com/fr/revues/medecine/bdc/e-docs/00/04/36/1F/article.md
2007
France
French
leukemia, myelogenous, chronic, bcr-abl positive
piperazines
pyrimidines
antineoplastic agents
journal article

---
http://www.lecrat.eu/?s=Pip%C3%A9razine
2006
France
French
pregnancy
piperazines
antinematodal agents
piperazine
piperazines
drug information
Piperazine

---
http://www.reseau-pic.info/?dest=medicaments/zopiclone.htm&med=ZOPICLONE®
2006
France
French
hypnotics and sedatives
sleep initiation and maintenance disorders
piperazines
hypnotics and sedatives
piperazines
azabicyclo compounds
azabicyclo compounds
zopiclone
piperazines
azabicyclo compounds
patient education handout

---
Nous contacter.
02/12/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.